Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptor superfamily ligand-activated transcription factors that include the following three subtypes: PPAR, PPAR, and PPAR/. Higher organisms' cellular differentiation, development, metabolism (carbohydrate, lipid, and protein), as well as tumorigenesis, are all crucially regulated by PPARs. All PPARs bind to particular regions of the target genes' DNA through heterodimerization with the retinoid X receptor (RXR). Triglyceride levels are reduced and energy homeostasis is regulated when PPAR- is activated. PPAR- activation improves the metabolism of glucose, whereas PPAR-/ activation improves the metabolism of fatty acids.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V10867 | Alpinetin | 36052-37-6 | Alpinetin is a natural flavonoid isolated from Alpinia katsumadai Hayata with potent anti-inflammatory activity. |
|
V4569 | Astaxanthin | 472-61-7 | Astaxanthin is a naturally occurring red dietary carotenoid isolated from Haematococcus pluvialis anda keto-carotenoid that belongs to a larger class of chemical compounds known as terpenes (as a tetraterpenoid) built from five carbon precursors, isopentenyl diphosphate, and dimethylallyl diphosphate. |
|
V0836 | Bezafibrate | 41859-67-0 | Bezafibrate (BM 15075; BM-15075; Benzofibrate;BM15075; Bezalip; Bezatrol; Difaterol; Cedur; Bezafibratum) is an anti-hypertriglyceridemic/lipid-lowering drug acting. |
|
V2840 | BMS-687453 | 1000998-59-3 | BMS-687453 is a potent and selective peroxisome proliferator activated receptor (PPAR) alpha agonist, with anEC50andIC50of 10 nM and 260 nM for humanPPARαand 4100 nM and >15000 nM for PPARγ in PPAR-GAL4 transactivation assays. |
|
V0833 | Ciprofibrate | 52214-84-3 | Ciprofibrate (BRN-1984981; CCRIS 173; CCRIS173;Win-35833; BRN 1984981; BRN1984981;CCRIS-173) is a potent and selective agonist of PPAR/peroxisome proliferator-activated receptor agonist with antilipidemic activity. |
|
V0837 | Clofibric Acid | 882-09-7 | Clofibric acid (BRN-1874067; CCRIS 9254;BRN1874067;NSC 1149; NSC1149;Chlorofibrinic acid), theactive metabolite of clofibrate, etofibrate and theofibrate (the lipid-lowering drugs), is a potentPPARα agonist and anti-hyperlipidemic agent. |
|
V0834 | Fenofibrate | 49562-28-9 | Fenofibrate (Tricor, Procetofen, LF-178, Lipanthyl, NSC-281319;Controlip,Normalip, Secalip, durafenat, Trilipix) is afibric acid based anti-hyperlipidemic drug of the fibrate class approved for clinical uses as a lipid-lowering agent. |
|
V0831 | FH535 | 108409-83-2 | FH535 (FH-535; FH 535) is a novel and potent dual inhibitor of the Wnt/β-catenin and the PPAR (γ/δ) pathways with potential antitumor activity. |
|
V0835 | Gemfibrozil | 25812-30-0 | Gemfibrozil (Pilder; CI-719;CI719;CI 719; Lopid; Jezil; Lipur; Trialmin) is a potent anti-hypertriglyceridemic/lipid lowering drug acting as an activator/agonist of peroxisome proliferator-activated receptor-alpha (PPARα). |
|
V0830 | GSK3787 | 188591-46-0 | GSK3787 (GSK-3787; GSK 3787) isa novel, potent, selective and irreversible antagonist of PPARδ (Peroxisome proliferator-activated receptor δ) with important biological activity. |
|
V0832 | GW0742 | 317318-84-6 | GW0742 (GW-0742; GW 0742; GW-0742X; GW0742X; GW610742; GW-610742) is a potent and highly selective PPARβ/δ agonist with potential anti-inflammatory activity. |
|
V4916 | GW6471 | 880635-03-0 | GW 6471 (GW6471; GW-6471) is a novel and potentPPARαantagonistwith an IC50 of 0.24 μ M. |
|
V0826 | GW9662 | 22978-25-2 | GW9662 (GW-9662; GW 9662) is an irreversible and selective inhibitor of PPAR (peroxisome proliferator-activated receptor) with potential anticancer activity. |
|
V30081 | Oroxin A | 57396-78-8 | Oroxin A is the major component of Oroxylum indicum (L. |
|
V17606 | Pemafibrate [(R)-K-13675] | 848259-27-8 | Pemafibrate [(R)-K 13675; K877; Parmodia], a drug used for the reduction of triglycerides,is a potent agonist ofperoxisome proliferator-activated receptor alpha(PPAR alpha/PPARα) with EC50 of 1 nM. |
|
V0828 | Pioglitazone | 111025-46-8 | Pioglitazone (U-72107A;AD-4833;Actos; AD4833, U-72107E) is approved and thiazolidinedione-based anti-diabetic drug which acts as a selective PPARϒ (Peroxisome proliferator-activated receptor γ) agonist with hypoglycemic activity. |
|
V0825 | Rosiglitazone | 122320-73-4 | Rosiglitazone (HSDB-7555; BRL-49653; TDZ-01; TDZ01; trade name Avandia)is an approved antidiabetic drug of the thiazolidinedione classwith antidiabetic properties and potential antineoplastic activity. |
|
V0838 | Rosiglitazone HCl | 302543-62-0 | Rosiglitazone HCl (HSDB-7555;BRL-49653;TDZ-01;BRL49653), the hydrochloride salt ofRosiglitazone,is a potent antidiabetic/antihyperglycemic drug of the thiazolidinedione class with anti-inflammatoryactivities. |
|
V0824 | Rosiglitazone maleate | 155141-29-0 | Rosiglitazone maleate (TDZ01;HSDB-7555; TDZ-01;BRL-49653; trade name Avandia), the maleic acid salt form of rosiglitazone which is an approved anti-diabetic drug,is a thiazolidinedione-based antihyperglycaemic agent with antidiabetic properties and potential antineoplastic activity. |
|
V0827 | T0070907 | 313516-66-4 | T0070907 (T-0070907; T 0070907) is a potent and selective PPARγ (Peroxisome proliferator-activated receptor γ) inhibitor with potential anti-inflammatory activity. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
